米诺环素在亨廷顿舞蹈病的表型小鼠模型中并无益处。 - Suppr

Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease.

作者信息

Diguet Elsa, Rouland Richard, Tison François

出版信息

Ann Neurol. 2003 Dec;54(6):841-2. doi: 10.1002/ana.10818.

DOI:10.1002/ana.10818

PMID:14681898

Abstract

摘要

相似文献

Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease.

Ann Neurol. 2003 Dec;54(6):841-2. doi: 10.1002/ana.10818.

Minocycline is protective in a mouse model of Huntington's disease.

Ann Neurol. 2003 Dec;54(6):841; author reply 842-3. doi: 10.1002/ana.21891.

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.

Nat Med. 2000 Jul;6(7):797-801. doi: 10.1038/77528.

Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease.

Eur J Neurosci. 2004 Jun;19(12):3266-76. doi: 10.1111/j.0953-816X.2004.03372.x.

Revisiting safety of minocycline as neuroprotection in Huntington's disease.

Mov Disord. 2007 Jan 15;22(2):292. doi: 10.1002/mds.21199.

Clinical potential of minocycline for neurodegenerative disorders.

Neurobiol Dis. 2004 Dec;17(3):359-66. doi: 10.1016/j.nbd.2004.07.012.

Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.

Mol Cell Neurosci. 2008 Sep;39(1):1-7. doi: 10.1016/j.mcn.2008.04.012. Epub 2008 May 10.

Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease.

Pharmacol Biochem Behav. 2009 Nov;94(1):148-53. doi: 10.1016/j.pbb.2009.08.001. Epub 2009 Aug 19.

Experimental therapeutics in transgenic mouse models of Huntington's disease.

Nat Rev Neurosci. 2004 May;5(5):373-84. doi: 10.1038/nrn1386.

Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.

Neuroscience. 2006 Sep 15;141(4):1835-48. doi: 10.1016/j.neuroscience.2006.05.043. Epub 2006 Jun 30.

引用本文的文献

Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease.

J Cell Mol Med. 2019 Feb;23(2):1581-1592. doi: 10.1111/jcmm.14113. Epub 2018 Dec 25.

Minocycline: far beyond an antibiotic.

Br J Pharmacol. 2013 May;169(2):337-52. doi: 10.1111/bph.12139.

Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease.

J Neurosci. 2008 Sep 17;28(38):9473-85. doi: 10.1523/JNEUROSCI.1867-08.2008.

Lack of minocycline efficiency in genetic models of Huntington's disease.

Neuromolecular Med. 2007;9(1):47-54. doi: 10.1385/nmm:9:1:47.

Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation.

BMC Neurosci. 2005 Jan 13;6:1. doi: 10.1186/1471-2202-6-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献